We are currently restructuring our databases, so be advised that the FCPAC database is updated only through July 30, 2025.

Processing your request


please wait...

 | Investigations Dataset

Stanford Foreign Corrupt Practices Act Clearinghouse a Collaboration with Sullivan & Cromwell LLP

Investigations Dataset

 
Investigation into Merck's Activities in Multiple Countries · Merck & Co., Inc.

Information & Summary

Investigation into Merck's Activities in Multiple Countries

Related FCPA Matter:   Merck's Involvement in Multiple Countries Information

Information & Summary

Investigation Name:    Investigation into Merck's Activities in Multiple Countries

Trend:    None

Type of investigation:    SEC, DOJ

Other Agencies Investigating/Assisting with SEC/DOJ Investigation:    Unknown

Whistleblower:    Unknown

Summary

Merck & Co., Inc. ("Merck") is an American multinational pharmaceutical company incorporated and headquartered in New Jersey. Its common stock is traded on the NYSE.

In its August 6, 2010 10-Q filing, Merck disclosed that it had received letters from the DOJ and the SEC seeking information about activities in a number of countries and referencing the Foreign Corrupt Practices Act. Merck disclosed that it cooperated with the agencies in their requests and that it believes that the inquiry is part of a broader review of pharmaceutical industry practices in foreign countries.

In its February 27, 2014 10-K filing, Merck disclosed that it had been advised by the DOJ that the DOJ had closed its inquiry into this matter. The SEC's investigation appears to be ongoing.

Protected Content


Please Log In or Sign Up for a free account to access restricted features of the Clearinghouse website, including the Advanced Search form and the full case pages.

When you sign up, you will have the option to save your search queries performed on the Advanced Search form.